Aprea Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aprea Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q3 2022.
  • Aprea Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $107K, a 57.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $107K -$142K -57.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $171K -$20.1K -10.5% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $242K -$6.02K -2.42% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $186K -$135K -42% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $249K -$112K -31% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $191K -$218K -53.3% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $248K -$197K -44.3% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $321K -$201K -38.5% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $361K -$200K -35.6% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $409K Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $446K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $521K Dec 31, 2019 10-K 2021-03-16
Q3 2019 $560K Sep 30, 2019 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.